APA (7th ed.) Citation

Yagi, Y., Kanemasa, Y., Sasaki, Y., Sei, M., Matsuo, T., Ishimine, K., . . . Haraguchi, K. (2023). Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study. Cancer Medicine, 12(17), 17808. https://doi.org/10.1002/cam4.6412

Chicago Style (17th ed.) Citation

Yagi, Yu, et al. "Clinical Outcomes in Transplant‐eligible Patients with Relapsed or Refractory Diffuse Large B‐cell Lymphoma After Second‐line Salvage Chemotherapy: A Retrospective Study." Cancer Medicine 12, no. 17 (2023): 17808. https://doi.org/10.1002/cam4.6412.

MLA (9th ed.) Citation

Yagi, Yu, et al. "Clinical Outcomes in Transplant‐eligible Patients with Relapsed or Refractory Diffuse Large B‐cell Lymphoma After Second‐line Salvage Chemotherapy: A Retrospective Study." Cancer Medicine, vol. 12, no. 17, 2023, p. 17808, https://doi.org/10.1002/cam4.6412.